Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Abiomed, Inc.
Abiomed, Inc. Announces Common Stock Offering
September 5th, 2008
Abiomed, Inc. (NASDAQ: ABMD) announced the public offering of 2,419,932 shares of its common stock. Morgan Stanley & Co. Incorporated will be the sole underwriter for the offering. The underwriter may offer the shares from time to time in one or more transactions in the over-the-counter market or through negotiated transactions at market prices or at negotiated prices. The offering is being made pursuant to a shelf registration statement that became effective on October 17, 2006. Keywords: Abiomed Inc., Biotechnology Business, Biotechnology Company, Abiomed Inc. This article was prepared by Health Business Week editors from staff...
Source: Health Business Week (2008-09-05)
|
